Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.
2.

Rheumatoid arthritis in patients with HIV: management challenges.

Carroll MB, Fields JH, Clerc PG.

Open Access Rheumatol. 2016 Apr 29;8:51-59. eCollection 2016 Apr 29. Review.

3.

Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter?

Mecoli CA, Delev NG, Bingham CO 3rd.

Clin Rheumatol. 2016 Dec;35(12):3053-3056. Epub 2016 Jul 29.

4.

Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial.

Akdemir G, Markusse IM, Dirven L, Riyazi N, Steup-Beekman GM, Kerstens P, Lems WF, Huizinga T, Allaart CF.

RMD Open. 2016 Mar 25;2(1):e000143. doi: 10.1136/rmdopen-2015-000143. eCollection 2016 Mar 25.

5.

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report.

Talotta R, Atzeni F, Sarzi Puttini P.

BMC Pharmacol Toxicol. 2016 Apr 21;17:17. doi: 10.1186/s40360-016-0060-2.

6.

Glucocorticoids and chronotherapy in rheumatoid arthritis.

Cutolo M.

RMD Open. 2016 Mar 18;2(1):e000203. doi: 10.1136/rmdopen-2015-000203. eCollection 2016 Mar 18. Review.

7.

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab.

Benucci M, Meacci F, Grossi V, Infantino M, Manfredi M, Bellio E, Bellio V, Li Gobbi F, Bazzichi L, Moscato P, Caputo D, Saviola G, Talotta R, Sarzi-Puttini P, Atzeni F.

Biologics. 2016 Mar 11;10:53-8. doi: 10.2147/BTT.S97234. eCollection 2016 Mar 11.

8.

Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach.

Nair SC, Jacobs JW, Bakker MF, Jahangier ZN, Bijlsma JW, van Laar JM, Lafeber FP, Welsing PM; Utrecht Arthritis Cohort Study Group..

PLoS One. 2016 Mar 17;11(3):e0148791. doi: 10.1371/journal.pone.0148791. eCollection 2016 Mar 17.

9.

Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate.

Lee WS, Lee SI, Lee MS, Kim SI, Lee SS, Yoo WH.

Korean J Intern Med. 2016 Jul;31(4):779-87. doi: 10.3904/kjim.2015.066. Epub 2016 Mar 10.

10.

Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study.

Akdemir G, Verheul MK, Heimans L, Wevers-de Boer KV, Goekoop-Ruiterman YP, van Oosterhout M, Harbers JB, Bijkerk C, Steup-Beekman GM, Lard LR, Huizinga TW, Trouw LA, Allaart CF.

RMD Open. 2016 Feb 15;2(1):e000172. doi: 10.1136/rmdopen-2015-000172. eCollection 2016 Feb 15.

11.

Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).

Heimans L, Akdemir G, Boer KV, Goekoop-Ruiterman YP, Molenaar ET, van Groenendael JH, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2016 Jan 21;18:23. doi: 10.1186/s13075-015-0912-y.

12.

Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009.

Herrinton LJ, Harrold L, Salman C, Liu L, Goldfien R, Asgari M, Gelfand JM, Wu JJ, Curtis JR.

Perm J. 2016 Winter;20(1):4-12. doi: 10.7812/TPP/15-028. Epub 2015 Dec 21.

13.

Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.

Charles-Schoeman C, Wang X, Lee YY, Shahbazian A, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, O'Dell J, Bathon JM, Paulus H, Bridges SL Jr, Curtis JR.

Arthritis Rheumatol. 2016 Mar;68(3):577-86. doi: 10.1002/art.39502.

14.

Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease.

Pasma A, Schenk CV, Timman R, Busschbach JJ, van den Bemt BJ, Molenaar E, van der Laan WH, Schrauwen S, Van't Spijker A, Hazes JM.

Arthritis Res Ther. 2015 Oct 8;17:281. doi: 10.1186/s13075-015-0801-4.

15.

A Case of Diverticular Perforation in a Young Patient with Rheumatoid Arthritis on Methotrexate.

Chang I, Guggenheim C, Laird-Fick H.

Case Rep Med. 2015;2015:617268. doi: 10.1155/2015/617268. Epub 2015 Apr 29.

16.

The impact of steroids, methotrexate, and biologics on clinical and radiographic outcomes in patients with rheumatoid arthritis undergoing fusions at the craniovertebral junction.

Khanna R, Dlouhy BJ, Smith ZA, Lam SK, Koski TR, Dahdaleh NS.

J Craniovertebr Junction Spine. 2015 Apr-Jun;6(2):60-4. doi: 10.4103/0974-8237.156044.

17.

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Van der Elst K, Meyfroidt S, Westhovens R; CareRA study group..

Arthritis Res Ther. 2015 Apr 9;17:97. doi: 10.1186/s13075-015-0611-8.

18.

Predictors of longterm changes in body mass index in rheumatoid arthritis.

Baker JF, Cannon GW, Ibrahim S, Haroldsen C, Caplan L, Mikuls TR.

J Rheumatol. 2015 Jun;42(6):920-7. doi: 10.3899/jrheum.141363. Epub 2015 Apr 1.

19.

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.

Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S1. doi: 10.1186/ar4685. Review.

20.

Gout initially mimicking rheumatoid arthritis and later cervical spine involvement.

Nunes EA, Rosseti AG Jr, Ribeiro DS, Santiago M.

Case Rep Rheumatol. 2014;2014:357826. doi: 10.1155/2014/357826. Epub 2014 Dec 9.

Supplemental Content

Loading ...
Support Center